Y
Yukitoshi Satoh
Researcher at Kitasato University
Publications - 174
Citations - 6676
Yukitoshi Satoh is an academic researcher from Kitasato University. The author has contributed to research in topics: Lung cancer & Adenocarcinoma. The author has an hindex of 33, co-authored 166 publications receiving 6030 citations. Previous affiliations of Yukitoshi Satoh include Japanese Foundation for Cancer Research.
Papers
More filters
Journal ArticleDOI
RET, ROS1 and ALK fusions in lung cancer.
Kengo Takeuchi,Manabu Soda,Yuki Togashi,Ritsuro Suzuki,Seiji Sakata,Satoko Hatano,Reimi Asaka,Wakako Hamanaka,Hironori Ninomiya,Hirofumi Uehara,Young Lim Choi,Yukitoshi Satoh,Yukitoshi Satoh,Sakae Okumura,Ken Nakagawa,Hiroyuki Mano,Hiroyuki Mano,Yuichi Ishikawa +17 more
TL;DR: A multivariate analysis of 1,116 adenocarcinomas containing 71 kinase-fusion–positive adenokcinomas identified four independent factors that are indicators of poor prognosis: age ≥50 years, male sex, high pathological stage and negative kinase -fusion status.
Journal ArticleDOI
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
Kengo Takeuchi,Young Lim Choi,Yuki Togashi,Manabu Soda,Satoko Hatano,Kentaro Inamura,Shuji Takada,Toshihide Ueno,Yoshihiro Yamashita,Yukitoshi Satoh,Sakae Okumura,Ken Nakagawa,Yuichi Ishikawa,Hiroyuki Mano +13 more
TL;DR: An intercalated antibody-enhanced polymer (iAEP) method that incorporates an intercalating antibody between the primary antibody to ALK and the dextran polymer-based detection reagents should prove suitable for immunohistochemical screening of tumors positive for ALK or ALK fusion proteins among pathologic archives.
Journal ArticleDOI
Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts
Kengo Takeuchi,Young Lim Choi,Manabu Soda,Kentaro Inamura,Yuki Togashi,Satoko Hatano,Munehiro Enomoto,Shuji Takada,Yoshihiro Yamashita,Yukitoshi Satoh,Sakae Okumura,Ken Nakagawa,Yuichi Ishikawa,Hiroyuki Mano +13 more
TL;DR: A multiplex reverse transcription-PCR system is developed that captures all in-frame fusions between EML4 to exon 20 of ALK to reinforce the importance of accurate diagnosis of E ML4-ALK–positive tumors for the optimization of treatment strategies.
Journal ArticleDOI
EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
Kentaro Inamura,Kengo Takeuchi,Yuki Togashi,Kimie Nomura,Hironori Ninomiya,Michiyo Okui,Yukitoshi Satoh,Sakae Okumura,Ken Nakagawa,Manabu Soda,Young Lim Choi,Toshiro Niki,Hiroyuki Mano,Yuichi Ishikawa +13 more
TL;DR: In the present first investigation of EML4-ALK fusion in a large study of lung cancers, an interesting histotype-genotype relationship is found and the fusion protein could be detected by immunohistochemistry, pointing to possible clinical applications.
Journal ArticleDOI
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
Toshiro Migita,Tadahito Narita,Kimie Nomura,Erika Miyagi,Fumika Inazuka,Masaaki Matsuura,Masaru Ushijima,Tetsuo Mashima,Hiroyuki Seimiya,Yukitoshi Satoh,Sakae Okumura,Ken Nakagawa,Yuichi Ishikawa +12 more
TL;DR: Findings suggest that ACLY is involved in lung cancer pathogenesis associated with metabolic abnormality and might offer a novel therapeutic target.